The group's principle activity is to provide cardiologists and surgeons to address a critical and underserved clinical need, and prevention and treatment of kidney dysfunction resulting from certain cardiovascular, endovascular, or surgical procedures and disease states. The group's products include Benephit(R) CV and PV infusion system, Benephit(R) PVSolo system, Benephit(R) PVMini system, and Benephit(R) XT infusion system. The group operates from United States.
